文献速递乳腺MR

分子亚型参考标准差异影响基于DCE-MRI的AI乳腺癌分类

Differences in Molecular Subtype Reference Standards Impact AI-based Breast Cancer Classification with Dynamic Contrast-enhanced MRI.
PubMed 文献 · Radiology · 2023-01-03

该回顾性研究分析了877个乳腺癌肿瘤的DCE-MRI影像组学特征,比较IHC与St Gallen两种参考标准对Luminal A/B分型的一致性。结果显示6个影像组学特征在一致与不一致肿瘤间存在差异,且仅使用两种标准均一致的肿瘤进行分类时AUC最高(0.74),提示参考标准差异可影响AI分类性能。

要点

  • IHC与St Gallen标准对Luminal A/B分型不一致时,肿瘤影像组学特征存在差异。
  • 仅用两标准一致的肿瘤训练分类器,AUC高于单用任一标准。
  • 参考标准的选择会影响AI分子亚型分类的效能,需在研究中明确。

关键影像表现/征象

  • 6个影像组学特征(球形度、不规则性、表面积与体积比、径向梯度直方图方差、和平均、最强强化体素体积)在一致与不一致肿瘤间存在差异(P ≤ .001)。
  • 影像上可见的征象未在原文中具体描述,仅涉及影像组学特征。

诊断标准与关键数值

  • 分类性能以AUC衡量:使用一致肿瘤时中位AUC为0.74(95% CI: 0.68, 0.80)。
  • 使用IHC标准分型时AUC为0.66(95% CI: 0.60, 0.71),与一致肿瘤相比P = .003。
  • 使用St Gallen标准分型时AUC为0.62(95% CI: 0.58, 0.67),与一致肿瘤相比P = .001。

临床应用与阅片要点

  • 在构建AI模型时,应明确分子亚型参考标准(IHC或St Gallen),并考虑标准间不一致对分类的影响。
  • 影像组学特征如球形度、不规则性等与肿瘤分子亚型相关,但需注意参考标准差异可能引入偏倚。

局限性

  • 回顾性研究设计。
  • 原文未报告其他明显局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Breast cancer tumors can be identified as different luminal molecular subtypes depending on either immunohistochemical (IHC) staining or St Gallen criteria that includes Ki-67. Purpose To characterize molecular subtypes and understand the impact of disagreement among IHC and St Gallen molecular subtype reference standards on artificial intelligence classification of luminal A and luminal B tumors with use of radiomic features extracted from dynamic contrast-enhanced (DCE) MRI scans. Materials and Methods In this retrospective study, 28 radiomic features previously extracted from DCE-MRI scans of breast tumors imaged between February 2015 and October 2017 were examined in the following groups: (a) tumors classified as luminal A by both reference standards ("agreement"), (b) tumors classified as luminal A by IHC and luminal B by St Gallen ("disagreement"), and (c) tumors classified as luminal B by both ("agreement"). Luminal A or luminal B tumor classification with use of radiomic features was conducted with use of three sets: (a) IHC molecular subtyping, (b) St Gallen molecular subtyping, and (c) agreement tumors. The Kruskal-Wallis test was followed by the Mann-Whitney U test to determine pair-wise differences of radiomic features among agreement and disagreement tumors. Fivefold cross-validation with use of stepwise feature selection and linear discriminant analysis classified tumors in each set, with performance measured with use of area under the receiver operating characteristic curve (AUC). Results A total of 877 breast cancer tumors from 872 women (mean age, 48 years [range, 19-75 years]) were analyzed. Six features (sphericity, irregularity, surface area to volume ratio, variance of radial gradient histogram, sum average, volume of most enhancing voxels) were different (P ≤ .001) among agreement and disagreement tumors. AUC (median, 0.74 [95% CI: 0.68, 0.80]) was higher than when using tumors subtyped by either reference standard (IHC, 0.66 [0.60, 0.71], P = .003; St Gallen, 0.62 [0.58, 0.67], P = .001). Conclusion Differences in reference standards can hinder artificial intelligence classification performance of luminal molecular subtypes with dynamic contrast-enhanced MRI. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Bae in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Ji, Whitney, Li, et al. Differences in Molecular Subtype Reference Standards Impact AI-based Breast Cancer Classification with Dynamic Contrast-enhanced MRI. Radiology. 2023. PMID: 36594836. doi:10.1148/radiol.220984

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。